| Background: Transcription factor 7-like 2 (TCF7L2)-rs7903146 polymorphism is associated with
increased risk of type 2 diabetes. The response of insulin and insulin resistance to artichoke leaf extract
(ALE) may be affected by TCF7L2-rs7903146 polymorphism.
Objective: This study examined the effects of ALE supplementation on metabolic parameters of the
TCF7L2-rs7903146 polymorphism in patients with metabolic syndrome (MetS).
Design, setting, participants and interventions: This double-blind clinical trial was conducted on 80 patients
with MetS in Sina Clinic, Khoy, Iran. The patients were randomized into ALE or placebo groups to receive
either ALE (1800 mg/d as four tablets) or matching placebo for 12 weeks.
Main outcome measures: Anthropometric indices, blood pressure, glucose and lipid profile levels were measured
before and after the study. Moreover, patients were genotyped for TCF7L2 polymorphism.
Results: ALE supplementation decreased insulin level and the homeostasis model assessment of insulin
resistance (HOMA-IR) in patients with the TT genotype of TCF7L2-rs7903146 polymorphism (P < 0.05).
There was no significant interaction between blood pressure, glucose and lipid profile response to ALE
supplementation.
Conclusion: The responses of insulin and HOMA-IR to ALE supplementation have shown an interaction with
single-nucleotide polymorphism rs7903146 in TCF7L2.
Trial registration: Iranian Registry of Clinical Trial IRCT201409033320N9. |